International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was RUB 213.38 million compared to RUB 192.48 million a year ago. Net income was RUB 108.87 million compared to RUB 76.6 million a year ago.
International Medical Center of Biomaterials Processing and Cryostorage Public
Equities
GEMA
RU000A100GC7
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
672 RUB | -0.22% |
|
-.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 114M | |
+25.85% | 87.86B | |
-22.73% | 76.69B | |
+3.24% | 26.86B | |
+2.00% | 17.76B | |
-0.42% | 15.22B | |
+72.40% | 13.56B | |
+81.96% | 13.37B | |
-24.56% | 13.01B | |
+25.01% | 12.7B |
- Stock Market
- Equities
- GEMA Stock
- News International Medical Center of Biomaterials Processing and Cryostorage Public
- International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company Reports Earnings Results for the Nine Months Ended September 30, 2023